Skip to main content

Carisma Therapeutics Inc.

CARMDelisted Dec 15, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001485003

Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Carisma Therapeutics Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of CARM: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders6971+2
Shares25.8M32.5M+6.63M (+25.7%)
Value$11.0M$19.8M+$8.80M (+80.2%)

New holders (13)

Institutions that held Carisma Therapeutics Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to CARM in Q4 2022
InstitutionSharesValue% of portfolio
BML Capital Management, LLC8,227,969$5.01M4.79%
Jane Street Group, LLC284,998$173.7K0.00%
Ergoteles LLC104,180$63.5K0.00%
Two Sigma Securities, LLC83,709$51.0K0.01%
ExodusPoint Capital Management, LP43,800$27.0K0.00%
HRT Financial LP32,382$19.0K0.00%
Ground Swell Capital, LLC28,543$17.4K0.08%
Two Sigma Advisers, LP22,600$13.8K0.00%
Cubist Systematic Strategies, LLC15,817$9.64K0.00%
StoneX Group Inc.13,000$7.92K0.00%
Belvedere Trading LLC8,092$4.94K0.00%
Spire Wealth Management1,000$1.00K0.00%
The PNC Financial Services Group, Inc.400$2440.00%

Sold out (11)

Institutions that held Carisma Therapeutics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of CARM in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Bridgeway Capital Management, LLC250,000$106.0K
Gsa Capital Partners LLP188,626$80.0K
LMR Partners LLP95,741$41.0K
Virtu Financial LLC72,808$31.0K
Balyasny Asset Management LLC70,675$30.0K
Goldman Sachs Group Inc69,014$29.0K
ProShare Advisors LLC16,777$7.00K
Mariner, LLC12,726$5.00K
Highland Capital Management, LLC10,000$4.00K
Allworth Financial LP5,593$2.00K
China Universal Asset Management Co., Ltd.1,868$1.00K